Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1964 1
1965 1
1968 1
1970 1
1973 2
1974 1
1980 1
1981 1
1982 1
1983 2
1984 1
1989 3
1990 1
1991 2
1992 2
1993 2
1994 2
1995 8
1996 9
1997 10
1998 17
1999 12
2000 18
2001 13
2002 13
2003 35
2004 22
2005 28
2006 41
2007 81
2008 79
2009 76
2010 129
2011 120
2012 135
2013 167
2014 171
2015 175
2016 168
2017 196
2018 196
2019 194
2020 212
2021 235
2022 183
Text availability
Article attribute
Article type
Publication date

Search Results

2,460 results
Results by year
Filters applied: . Clear all
Page 1
KASL clinical practice guidelines: Management of nonalcoholic fatty liver disease.
Kang SH, Lee HW, Yoo JJ, Cho Y, Kim SU, Lee TH, Jang BK, Kim SG, Ahn SB, Kim H, Jun DW, Choi JI, Song DS, Kim W, Jeong SW, Kim MY, Koh H, Jeong S, Lee JW, Cho YK; Korean Association for the Study of the Liver (KASL). Kang SH, et al. Clin Mol Hepatol. 2021 Jul;27(3):363-401. doi: 10.3350/cmh.2021.0178. Epub 2021 Jun 22. Clin Mol Hepatol. 2021. PMID: 34154309 Free PMC article. No abstract available.
2020 Seoul Consensus on the Diagnosis and Management of Gastroesophageal Reflux Disease.
Jung HK, Tae CH, Song KH, Kang SJ, Park JK, Gong EJ, Shin JE, Lim HC, Lee SK, Jung DH, Choi YJ, Seo SI, Kim JS, Lee JM, Kim BJ, Kang SH, Park CH, Choi SC, Kwon JG, Park KS, Park MI, Lee TH, Kim SY, Cho YS, Lee HH, Jung KW, Kim DH, Moon HS, Miwa H, Chen CL, Gonlachanvit S, Ghoshal UC, Wu JCY, Siah KTH, Hou X, Oshima T, Choi MY, Lee KJ; Korean Society of Neurogastroenterology and Motility. Jung HK, et al. Among authors: kang sh. J Neurogastroenterol Motil. 2021 Oct 30;27(4):453-481. doi: 10.5056/jnm21077. J Neurogastroenterol Motil. 2021. PMID: 34642267 Free PMC article. Review.
CD226hiCD8+ T Cells Are a Prerequisite for Anti-TIGIT Immunotherapy.
Jin HS, Ko M, Choi DS, Kim JH, Lee DH, Kang SH, Kim I, Lee HJ, Choi EK, Kim KP, Yoo C, Park Y. Jin HS, et al. Among authors: kang sh. Cancer Immunol Res. 2020 Jul;8(7):912-925. doi: 10.1158/2326-6066.CIR-19-0877. Epub 2020 Apr 7. Cancer Immunol Res. 2020. PMID: 32265229
Edoxaban Versus Dual Antiplatelet Therapy for Leaflet Thrombosis and Cerebral Thromboembolism After TAVR: The ADAPT-TAVR Randomized Clinical Trial.
Park DW, Ahn JM, Kang DY, Kim KW, Koo HJ, Yang DH, Jung SC, Kim B, Wong YTA, Lam CCS, Yin WH, Wei J, Lee YT, Kao HL, Lin MS, Ko TY, Kim WJ, Kang SH, Yun SC, Lee SA, Ko E, Park H, Kim DH, Kang JW, Lee JH, Park SJ; ADAPT-TAVR Investigators. Park DW, et al. Among authors: kang sh. Circulation. 2022 Aug 9;146(6):466-479. doi: 10.1161/CIRCULATIONAHA.122.059512. Epub 2022 Apr 4. Circulation. 2022. PMID: 35373583 Clinical Trial.
Mesenchymal stem cells to treat liver diseases.
Eom YW, Kang SH, Kim MY, Lee JI, Baik SK. Eom YW, et al. Among authors: kang sh. Ann Transl Med. 2020 Apr;8(8):563. doi: 10.21037/atm.2020.02.163. Ann Transl Med. 2020. PMID: 32775364 Free PMC article. Review.
2,460 results